Dr. Philip Scheltens
Dr. Philip Scheltens is Professor of Cognitive Neurology and the Director of the Alzheimer Center at the VU University Medical Center in Amsterdam. He is also the initiator and Vice President of Deltaplan Dementia Netherlands. In 2011 Dr. Scheltens was appointed scientific director at the Pearlstring Institute and elected a Member of the Royal Netherlands Academy of Arts and Sciences, where he is now a member of the Board. He is an Honorary Professor of Neurology at University College London.
His main clinical and research interests are Alzheimer’s disease, vascular dementia, frontotemporal dementia, magnetic resonance imaging, PET imaging and biomarkers for disease detection and early diagnosis. He is active in the field of biomarkers and clinical trials and has been the national Primary Investigator for many trials, including phase 1-3 international multicenter clinical trials.
Dr. Scheltens is an active collaborator and contributor to many fields and is currently a member of various research societies including the European Academy of Neurology, the Dutch Society for Neurology, the American Academy of Neurology, the Alzheimer Imaging Consortium, and the ISTAART Consortium. He is also a jury member of the Brain Prize and a member of the organizing committee for the VASCOG conference 2016 in Amsterdam. From 2017 he is (again) a member of the AAIC program committee.
Dr. Scheltens received his MD in 1984 and his PhD in 1993 from the VU University in Amsterdam.
- 2016 Philip Scheltens Advisor Fellow: Dr. Anouk den Braber, Genetic and environmental influences on early AD biomarkers: a twin approach
- 2017 Philip Scheltens Advisor Fellow: Dr. Anouk den Braber, Risk factors for amyloid pathology and cognitive decline